Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment - A Randomized Controlled Trial

NCT05797558 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT05797558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05797558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment - A Randomized Controlled Trial
Lead sponsor
Göteborg University
Phase
Not applicable
Overall status
Recruiting
Start date
April 28, 2023
Completion date
May 28, 2028
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

primary hyperaldosteronism due to adrenal adenoma